85 related articles for article (PubMed ID: 26797321)
1. The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4.
Zhang T; Zhang X; Shi W; Xu J; Fan H; Zhang S; Ni R
Pathol Res Pract; 2016 Mar; 212(3):153-61. PubMed ID: 26797321
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
3. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C
Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601
[TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
5. Expression of Pirh2, a p27(Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27(Kip1) and cell proliferation.
Huang X; Qian X; Cheng C; He S; Sun L; Ke Q; Zhang L; Pan X; He F; Wang Q; Meng J; Ni R; Shen A
Hum Pathol; 2011 Apr; 42(4):507-15. PubMed ID: 21236467
[TBL] [Abstract][Full Text] [Related]
6. The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response.
Brenkman AB; van den Broek NJ; de Keizer PL; van Gent DC; Burgering BM
FASEB J; 2010 Nov; 24(11):4271-80. PubMed ID: 20570964
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
[TBL] [Abstract][Full Text] [Related]
8. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778
[TBL] [Abstract][Full Text] [Related]
10. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma.
Jiang D; Hu B; Wei L; Xiong Y; Wang G; Ni T; Zong C; Ni R; Lu C
Pathol Res Pract; 2015 Mar; 211(3):240-7. PubMed ID: 25547899
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. The contribution of XRCC6/Ku70 to hepatocellular carcinoma in Taiwan.
Hsu CM; Yang MD; Chang WS; Jeng LB; Lee MH; Lu MC; Chang SC; Tsai CW; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):529-35. PubMed ID: 23393345
[TBL] [Abstract][Full Text] [Related]
14. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
15. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
[TBL] [Abstract][Full Text] [Related]
16. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice.
Teoh NC; Dan YY; Swisshelm K; Lehman S; Wright JH; Haque J; Gu Y; Fausto N
Hepatology; 2008 Jun; 47(6):2078-88. PubMed ID: 18506893
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
18. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Zhang X; Xu P; Ni W; Fan H; Xu J; Chen Y; Huang W; Lu S; Liang L; Liu J; Chen B; Shi W
Pathol Res Pract; 2016 Mar; 212(3):162-70. PubMed ID: 26804244
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
